SMTL ID : 5zae.1

uPA-6F-HMA

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 1.73 Å

Oligo State

monomer

Ligands

1 x EAU: 3-azanyl-5-(azepan-1-yl)-N-carbamimidoyl-6-(furan-2-yl)pyrazine-2-carboxamide(Non-covalent)

EAU.1: 14 residues within 4Å: Chain A: H.46, D.192, S.193, C.194, Q.195, S.198, V.216, S.217, W.218, G.219, G.221, C.222, G.229 Ligands: SO4.2 12 PLIP interactions: 12 interactions with chain A Hydrophobic interactions: A:Q.195 Hydrogen bonds: A:S.193, A:S.193, A:Q.195, A:S.198, A:R.220 Water bridges: A:D.192, A:S.198, A:S.198, A:S.217, A:V.230 Salt bridges: A:D.192

1 x SO4: SULFATE ION(Non-functional Binders)

SO4.2: 8 residues within 4Å: Chain A: V.30, C.31, H.46, Y.150, Q.195, G.196, S.198 Ligands: EAU.1 9 PLIP interactions: 9 interactions with chain A Hydrogen bonds: A:Q.195, A:G.196, A:S.198, A:S.198, A:S.198 Water bridges: A:V.30, A:V.30, A:Y.150 Salt bridges: A:H.46

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Buckley, B.J. et al., 6-Substituted Hexamethylene Amiloride (HMA) Derivatives as Potent and Selective Inhibitors of the Human Urokinase Plasminogen Activator for Use in Cancer. J. Med. Chem. (2018)

Release Date

2018-12-19

Peptides

Urokinase-type plasminogen activator chain B: A

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
U

Urokinase-type plasminogen activator chain B

Related Entries With Identical Sequence